Early intervention can significantly improve the development and prognosis of T1DM, and effective biomarkers are great significance for the early prediction and diagnosis of T1DM. As a diabetes focused solution provider, Ace Therapeutics has established a multi-functional CRO platform service. We can provide researchers engaged in biomarker development of diabetes with more efficient function analysis. Learn more: gut microbiota biomarker development